Medical device company Stryker has announced it will acquire a San Francisco-based medtech company that specialises in advanced visualisation devices for surgery.
Acquisition
Stryker will acquire Invuity for the total sum of $190 million in a move which the company hopes improves patient outcomes through the combination of Stryker’s experience in minimal access surgery and Invuity’s visualisation expertise.
Scott Flora, Invuity’s interim chief executive officer, said: “The combination of Stryker's established leadership in minimal access surgery paired with Invuity’s suite of enabling visualization and surgical devices should facilitate better patient outcomes and operating room efficiencies in women’s health, general surgery, electrophysiology and orthopaedics. It is with this in mind that Invuity's Board of Directors voted to recommend this transaction to Invuity’s stockholders."
Spencer S. Stiles, group president, Neurotechnology, Instruments and Spine said: “Invuity’s innovative products in the single-use lighted instrumentation and hybrid energy markets provide best in class illumination and help make surgery safer. I look forward to the work we will do together to advance Stryker’s mission of making healthcare better.”